All Infection Prevention & Control articles – Page 3
-
NewsResearchers to study how much MRSA is lurking in the air in hospitals
Scientists are working to minimize health care workers’ exposure to MRSA, or methicillin-resistant Staphylococcus aureus, a type of staph bacteria that’s become resistant to many of the antibiotics used to treat ordinary staph infections.
-
NewsMonoclonal antibodies offer hope for tackling antimicrobial resistance
Monoclonal antibodies – treatments developed by cloning a cell that makes an antibody – could help provide an answer to the growing problem of antimicrobial resistance, say scientists.
-
NewsWyss Institute selected to develop biologically engineered broad-spectrum antimicrobial therapeutic
The Wyss Institute for Biologically Inspired Engineering at Harvard University received a contract for up to $12M from the new SHIELD program which aims to develop a prophylactic treatment that can rapidly clear multiple bloodborne bacterial and fungal pathogens.
-
NewsSome guidelines for diagnosis and treatment of hepatitis E virus infection need a revamp, evaluation finds
A systematic evaluation of HEV infection guidelines revealed significant variability in their quality and recommendations. While some demonstrated strengths, others were found lacking in stakeholder involvement, rigor of development, and applicability.
-
NewsTriple antibody therapy shows promise for long-lasting HIV control
A cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV, a new study shows. Some participants showed long-term control of the virus months after antibody levels declined to low or undetectable.
-
NewsNewly discovered antimicrobial could prevent or treat cholera
Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection. A study identifies the first known microcin that targets the strains of bacteria that cause cholera.
-
NewsConscience announces top performers in open science challenge to design promising pan-coronavirus drugs
The nonprofit drug discovery biotech Conscience has released seven newly discovered promising early-stage molecules that could lead to a new treatment effective against all coronaviruses, not just SARS-CoV-2.
-
NewsTiny heroes and innovative technology can fight back against antibiotic-resistant biofilms
Researchers show that antibiotic-infused silver nanoparticles can effectively break down biofilms and also unveil a new sensing method to assess antimicrobial activity.
-
NewsInnovative implant material combines osteogenic and antibacterial properties for superior bone repair
A new study introduces a novel polyetheretherketone (PEEK)-based implant material that not only promotes bone growth but also possesses potent antibacterial capabilities.
-
NewsStudy on E. coli outbreak in the UK demonstrates increasing impact of climate change on public health and food security
A study to investigate an UK E. coli outbreak identified contaminated lettuce as the most likely source of the infection, and determined that heavy rainfall and flooding may have carried STEC from animal feces to the lettuce crops.
-
NewsResearchers discover an effective and environment-friendly disinfectant
Researchers have discovered a promising alternative to chloroxylenol that works more effectively in combating certain common bacteria, fungi and viruses, and can be rapidly degraded and detoxified in receiving waters.
-
NewsFirst sustained remission of HIV infection following a bone marrow transplant in the absence of protective mutation
A total of seven individuals worldwide (two patients in Berlin and patients in London, Düsseldorf, New York, City of Hope and Geneva) are considered likely to have been cured or to be in long-term remission of HIV infection after receiving a bone marrow transplant to treat blood cancer. ...
-
NewsChristian Gaebler receives ERC Starting Grant to study HIV patients living without medication
Prof. Christian Gaebler aims to develop treatments that cure HIV infection in patients or prompt the immune system to keep the virus in check in the long term, and has won funding to study patients who are already living without medication.
-
NewsWound peptides can help detect dangerous infections more quickly
After identifying unique peptide patterns and changes in these patterns based on different types of bacteria in wounds, researchers can now assess the severity of the infection, a new study reveals.
-
NewsSaline nasal drops reduce the duration of the common cold in young children by two days
Using hypertonic saline nasal drops can reduce the length of the common cold in children by two days, according to a study that will be presented at the European Respiratory Society (ERS) Congress.
-
NewsNew guideline for Helicobacter pylori includes change to primary treatment recommendation
New guidelines on the treatment of Helicobacter pylori (H. pylori) infection warn against prescribing PPI triple therapy, instead advising practitioners to use bismuth quadruple therapy or one of the other suggested treatment options.
-
NewsFungus uses surface protein of its spores to weaken human immune system
An international research team discovered a special enzyme on the surface of the spores of Aspergillus fumigatus apparently suppresses the release of pro-inflammatory substances by immune cells, making it easier for the pathogen to spread in the tissue.
-
NewsPublic health experts put out call for collaboration in antiviral therapeutics development coalition
Establishing a global therapeutics development coalition is a vital next step to invigorate the therapeutics pipeline and drive advocacy for increased investment and coordination of end-to-end therapeutics development, say a group of public health experts.
-
NewsResearchers discover key gene regulating virulence of fungus that causes severe lung infections
Scientists have found a potential target for novel therapeutic strategies to combat fungal infections caused by Aspergillus fumigatus and are now looking for a molecule that inactivates the protein expressed by the gene as a basis for a drug.
-
NewsInfections following hip replacement associated with an increased risk of death, study finds
Patients who develop a periprosthetic joint infection (PJI) after a total hip replacement have more than a five-fold increased risk of mortality within 10 years, according to new research.
